{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:36:23Z","timestamp":1791905783278,"version":"4.3.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Shionogi & Co., Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/jac\/dky425","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T11:09:41Z","timestamp":1539860981000},"page":"380-386","source":"Crossref","is-referenced-by-count":101,"title":["<i>In vitro<\/i>activities of cefiderocol, ceftolozane\/tazobactam, ceftazidime\/avibactam and other comparative drugs against imipenem-resistant<i>Pseudomonas aeruginosa<\/i>and<i>Acinetobacter baumannii<\/i>, and<i>Stenotrophomonas maltophilia<\/i>, all associated with bloodstream infections in Taiwan"],"prefix":"10.1093","volume":"74","author":[{"given":"Shun-Chung","family":"Hsueh","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuarn-Jang","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Far Eastern Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsing","family":"Liao","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Far Eastern Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-9225","authenticated-orcid":false,"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"key\n\t\t\t\t2019011807282913700_dky425-B1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cid\/cit020","article-title":"The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia","volume":"56","author":"Molton","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jgar.2014.02.007","article-title":"High burden of antimicrobial drug resistance in Asia","volume":"2","author":"Lai","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jmii.2016.12.001","article-title":"Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan","volume":"50","author":"Lee","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jmii.2016.08.025","article-title":"Emergence of carbapenem-resistant Acinetobacter baumannii ST787 in clinical isolates from blood in a tertiary teaching hospital in Northern Taiwan","volume":"50","author":"Hu","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jmii.2015.04.004","article-title":"Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance","volume":"50","author":"Lin","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?","volume":"23","author":"Wright","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime\/avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B9","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/AAC.03098-15","article-title":"Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases","volume":"60","author":"Ito-Horiyama","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00093-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against a recent collection of clinically relevant Gram-negative bacilli from North America and Europe, including carbapenem-nonsusceptible isolates (SIDERO-WT-2014 Study)","volume":"61","author":"Hackel","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01968-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of Gram-negative bacilli collected worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B12","volume-title":"Abstracts of the Twenty-eighth European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain","author":"Nordmann","year":"2018"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B13","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JCM.01233-14","article-title":"Evaluation of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of blood isolates of Acinetobacter species","volume":"52","author":"Hsueh","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B14","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth Informational Supplement M100-S28","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B15","volume-title":"Clinical Breakpoints (version 8.0, 2018)","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2018"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2017.03.011","article-title":"Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller\u2013Hinton broth using a CLSI M23-A4 multi-laboratory study design","volume":"88","author":"Huband","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jcph.841","article-title":"Cefiderocol, a siderophore cephalosporin for Gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment","volume":"57","author":"Katsube","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B18","volume-title":"Abstracts of the Twenty-eighth European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain","author":"Tsuji","year":"2018"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B19","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1128\/AAC.00629-13","article-title":"Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa","volume":"57","author":"Tomaras","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011807282913700_dky425-B20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/2\/380\/27524620\/dky425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T05:43:15Z","timestamp":1662270195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/2\/380\/5144002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,23]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky425","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,23]]}}}